FindMyKOL
Clinical trialNCT00650988CompletedPhase Early 1Interventional

Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers

NCT00650988 is a phase early 1 interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barretts Esophagus and Esophageal Cancer. The registry lists an enrollment of 37 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2005 and a primary completion date of 31 May 2008.

SponsorCase Comprehensive Cancer Center →Enrollment37Barretts EsophagusEsophageal Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00650988
FieldValue
Registry IDNCT00650988
StatusCompleted
PhasePhase Early 1
Study typeInterventional trial
Lead sponsorCase Comprehensive Cancer Center
Enrollment37
Registered sites1
Countries1
ConditionsBarretts Esophagus and Esophageal Cancer
Start30 Sept 2005
Primary completion31 May 2008
Study completion31 Dec 2008
Last update posted24 Dec 2012

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a single center study to evaluate the efficacy and safety of a new ablation technique involving the spray of liquid nitrogen through a catheter (cryotherapy) via an upper endoscopy (EGD) to ablate Barrett's esophagus with changes of high-grade dysplasia (HGD) or intramucosal cancer (IMCA) and patients with esophageal cancer limited to the esophageal wall, in whom there are no standard treatment options available.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • the Cleveland Clinic

    Cleveland

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00650988

Each answer restates registry values shown on this page.

What is NCT00650988?

NCT00650988 is a phase early 1 interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barretts Esophagus and Esophageal Cancer.

Who leads NCT00650988?

The registry names John A. Dumot, D.O. (principal investigator, The Cleveland Clinic) as the overall official.

Where does NCT00650988 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT00650988 end?

The registry lists a primary completion date of 31 May 2008 and a study completion date of 31 Dec 2008. The sponsor last updated the record on 24 Dec 2012.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.